| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2002-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a1441029e24a039d29b2d7d6aebc73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_129ff822b2a92c130000bc996a77e281 |
| publicationDate |
2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004062765-A1 |
| titleOfInvention |
LFA-1 alpha subunit antibodies and methods of use |
| abstract |
Antibodies useful for and methods of treating LFA-1 alpha subunit associated physiological conditions and diseases treatable with an antibody that binds LFA-1 alpha subunit, such as HIV, are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007070488-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951306-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951306-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008311130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007070488-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2983711-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014140997-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8021668-B2 |
| priorityDate |
2002-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |